As of Feb 12
| +0.03 / +1.73%|
The 4 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 7.50, with a high estimate of 13.00 and a low estimate of 7.00. The median estimate represents a +326.14% increase from the last price of 1.76.
The current consensus among 4 polled investment analysts is to Buy stock in Catalyst Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.